Summary by Moomoo AI
Hansoh Pharma Group Limited announced on June 27, 2024 that it granted a total of 11,397,590 restricted share units to 616 grantees under the restricted share unit plan adopted on May 27, 2019. This includes two company directors, Ms. Sun Yuan who was granted 1,300,000 shares and Dr. Lui Aifeng who was granted 291,850 shares, as well as 614 company employees. The purchase price of the restricted share units was HK$3.379 per share, and the closing price on the date of grant was HK$16.48 per share. The vesting period of the restricted share units is three years and includes performance targets and clawback mechanisms. This plan does not involve the issuance of new shares and does not require shareholder approval.